Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 256–270 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4050 F2 (Prothrombin) Gene Mutation Analysis (NGS) Test This test detects the G20210A mutation in the F2 (Prothrombin) gene, a common inherited risk factor for venous thromboembolism.	Peripheral whole blood (3–5 mL in EDTA tube) or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["G20210A mutation in the F2 gene", "Inherited thrombophilia risk"] Parameters [{"name": "G20210A Mutation Status", "reference_range": "Negative/Positive"}] Preparation ["No special preparation is required"] Indications ["Evaluation of inherited thrombophilia", "Risk assessment for VTE", "Pre-surgical assessment in high-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 59228-8 ICD-10: D68.51 Clinical summary This test detects the G20210A mutation in the F2 (Prothrombin) gene, a common inherited risk factor for venous thromboembolism.
TEST-6261 F5 Gene Factor V Deficiency Genetic Test This test evaluates the F5 gene for pathogenic variants associated with Factor V deficiency.	Peripheral Whole Blood or DNA Extract	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["F5 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Suspected Factor V deficiency", "Personal or family history of bleeding disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55383-1 ICD-10: D68.51 Clinical summary This test evaluates the F5 gene for pathogenic variants associated with Factor V deficiency.
TEST-3879 Factor XI Deficiency (F11) Gene Sequencing Test (NGS) This test evaluates the F11 gene for pathogenic variants associated with hereditary Factor XI deficiency.	Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["F11 gene sequence", "Pathogenic variants in coding exons and splice junctions"] Parameters [] Preparation ["Pre-genetic counseling session is mandatory", "No fasting required", "Inform team if on anticoagulants"] Indications ["Suspected hereditary Factor XI deficiency", "Personal or family history suggestive of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 83142-5 ICD-10: D68.1 Clinical summary This test evaluates the F11 gene for pathogenic variants associated with hereditary Factor XI deficiency.
TEST-5826 FAH Gene Tyrosinemia Type 1 Genetic Test This test evaluates the FAH gene for pathogenic variants associated with Tyrosinemia Type 1.	Peripheral whole blood (3 ml EDTA) or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAH gene sequence", "Pathogenic variants (SNVs, indels, splice-site variants)"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected Tyrosinemia Type 1", "Family history of Tyrosinemia Type 1", "Screening in high-risk populations"] Measurement technique Confirm with laboratory Codes LOINC: 94851-1 ICD-10: E70.21 Clinical summary This test evaluates the FAH gene for pathogenic variants associated with Tyrosinemia Type 1.
TEST-5450 FAM20A Gene Amelogenesis Imperfecta Type 1G Genetic Test This genetic test evaluates the FAM20A gene for pathogenic variants associated with Amelogenesis Imperfecta Type IG.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAM20A gene sequence variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions"] Indications ["Diagnosis of Amelogenesis Imperfecta Type IG", "Identification of FAM20A gene mutations", "Genetic counseling for affected families", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 96208-4 ICD-10: K00.5 Clinical summary This genetic test evaluates the FAM20A gene for pathogenic variants associated with Amelogenesis Imperfecta Type IG.
TEST-4612 FAM20C Gene Raine Syndrome Genetic Test This test identifies pathogenic variants in the FAM20C gene associated with Raine syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAM20C gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation [] Indications ["Clinical suspicion of Raine syndrome", "Documented family history of Raine syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94762-2 ICD-10: Q78.8 Clinical summary This test identifies pathogenic variants in the FAM20C gene associated with Raine syndrome.
TEST-6274 Fanconi Anemia Type D2 (FANCD2) Gene Genetic Test This test identifies pathogenic variants within the FANCD2 gene associated with Fanconi anemia type D2.	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FANCD2 gene", "Copy number variants (CNVs) in the FANCD2 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Diagnosis of Fanconi anemia type D2", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 101516-4 ICD-10: D61.01, Z14.8, Z13.7 Clinical summary This test identifies pathogenic variants within the FANCD2 gene associated with Fanconi anemia type D2.
TEST-5243 FBLN5 Gene Cutis Laxa Type 1A Genetic Test This diagnostic test evaluates the FBLN5 gene for pathogenic variants associated with autosomal recessive cutis laxa type 1A.	Peripheral Whole Blood (EDTA), FTA Card, or Extracted Genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBLN5 gene sequence", "Pathogenic variants in FBLN5"] Parameters [] Preparation ["No fasting required", "No medication adjustments needed"] Indications ["Suspected cutis laxa type 1A", "Family history of cutis laxa type 1A", "Carrier screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81254-5 ICD-10: Q82.8 Clinical summary This diagnostic test evaluates the FBLN5 gene for pathogenic variants associated with autosomal recessive cutis laxa type 1A.
TEST-2820 FBN1 Gene Geleophysic Dysplasia Type 2 Genetic Test This test identifies pathogenic variants in the FBN1 gene associated with Geleophysic Dysplasia Type 2.	Peripheral whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBN1 gene sequence", "FBN1 gene copy number variations (deletions/duplications)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Geleophysic Dysplasia Type 2", "Family history of FBN1-related disorders", "Need for genetic confirmation for clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the FBN1 gene associated with Geleophysic Dysplasia Type 2.
TEST-6383 FBP1 Gene Fructose-1,6-Bisphosphatase Deficiency Genetic Test This genetic test identifies mutations in the FBP1 gene associated with fructose-1,6-bisphosphatase deficiency.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBP1 gene mutations", "Single nucleotide variants", "Small deletions or duplications"] Parameters [] Preparation ["Genetic counselling session required", "Detailed family pedigree documentation", "Full clinical history recording"] Indications ["Suspected fructose-1,6-bisphosphatase deficiency", "Newborn screening follow-up", "Family history of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 94124-8 ICD-10: E74.04 Clinical summary This genetic test identifies mutations in the FBP1 gene associated with fructose-1,6-bisphosphatase deficiency.
TEST-5511 FBXO7 Gene PARK15 Parkinson Genetic Test This diagnostic test evaluates the FBXO7 gene for pathogenic variants associated with autosomal recessive juvenile-onset parkinsonism (PARK15). It utilizes Next-Generation Sequenci...	Whole Blood (3-5 mL EDTA), Extracted DNA (≥1 μg at ≥50 ng/μL), or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBXO7 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)", "Copy Number Variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% via ISO-Accredited NGS Processing"}, {"name": "Analytical Sensitivity", "reference_range": ">99.5% for SNVs, indels, CNVs at minimum 100× read depth"}, {"name": "Methodology", "reference_range": "NGS (Next-Generation Sequencing) with CNV Analysis"}] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Patients presenting with early-onset parkinsonism", "Differential diagnosis of early-onset movement disorders", "Family history suggestive of autosomal recessive parkinsonism"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G20 Clinical summary This diagnostic test evaluates the FBXO7 gene for pathogenic variants associated with autosomal recessive juvenile-onset parkinsonism (PARK15). It utilizes Next-Generation Sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-4799 FCGR2B Gene Malaria Resistance Test This test evaluates genetic variants within the FCGR2B gene associated with innate resistance to severe malaria.	Peripheral blood (venous or FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FCGR2B gene variants", "Innate susceptibility to severe malaria"] Parameters [] Preparation [] Indications ["Individuals with a family history of malaria infections", "Personalized risk assessment for malaria susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 88825-8 ICD-10: Z13.89 Clinical summary This test evaluates genetic variants within the FCGR2B gene associated with innate resistance to severe malaria.
TEST-4830 FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 (LAD3) Genetic Test This genetic test identifies pathogenic variants in the FERMT3 gene, confirming a diagnosis of Leukocyte Adhesion Deficiency Type 3 (LAD3).	Whole blood (EDTA), extracted DNA, or one drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FERMT3 gene", "Copy Number Variations (CNVs) in FERMT3"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Mandatory clinical history review and genetic counselling session before sample collection"] Indications ["Suspected Leukocyte Adhesion Deficiency Type 3", "Family history of LAD3", "Recurrent severe infections with bleeding"] Measurement technique Confirm with laboratory Codes LOINC: 49863-9 ICD-10: D72.0 Clinical summary This genetic test identifies pathogenic variants in the FERMT3 gene, confirming a diagnosis of Leukocyte Adhesion Deficiency Type 3 (LAD3).
TEST-2717 FGF8 Gene Hypogonadotropic Hypogonadism Type 6 Genetic Test This test detects pathogenic variants in the FGF8 gene associated with autosomal dominant hypogonadotropic hypogonadism type 6.	Peripheral Whole Blood (3-5 mL in EDTA) or Extracted Genomic DNA (minimum 500 ng)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGF8 gene sequence", "Pathogenic variants in FGF8"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "Provide a detailed three-generation family pedigree"] Indications ["Suspected hypogonadotropic hypogonadism type 6", "Family history of hypogonadotropic hypogonadism", "Need for genetic confirmation for treatment planning"] Measurement technique Confirm with laboratory Codes LOINC: 21674-5 ICD-10: E23.0 Clinical summary This test detects pathogenic variants in the FGF8 gene associated with autosomal dominant hypogonadotropic hypogonadism type 6.
TEST-2215 FGFR1 Gene Trigonocephaly Type 1 Genetic Test This test analyzes the FGFR1 gene for pathogenic variants associated with trigonocephaly type 1 and related craniosynostosis syndromes.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR1 gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["Provide detailed clinical history", "Provide three-generation family pedigree", "Attend mandatory genetic counselling session"] Indications ["Diagnosis of trigonocephaly type 1", "Diagnosis of related craniosynostosis syndromes", "Familial genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 51969-6 ICD-10: Q75.0, Q87.0, Z13.71 Clinical summary This test analyzes the FGFR1 gene for pathogenic variants associated with trigonocephaly type 1 and related craniosynostosis syndromes.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.